News & Information | START In The News

Welcome to START’s News & Information page.  Here you'll find the latest news releases and articles about START. Take a moment to browse through some of the stories that have been written about START.

April 22nd, 2008

Calando Receives FDA Approval for Phase I Clinical Trial Using a Targeted siRNA Nanoparticle Therapeutic

Calando Pharmaceuticals, a majority owned subsidiary of Arrowhead Research Corporation, announced today that the U.S. Food and Drug Administration (FDA) has approved its investigational new drug application (IND) for lead anti-cancer compound, CALAA-01.